Foghorn Therapeutics Inc. (FHTX) Stock

Foghorn Therapeutics Inc. (FHTX) is a Healthcare stock trading at $4.17 (as of 2026-06-18), with a market capitalization of $251.30M and a trailing P/E of -3.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Foghorn Therapeutics Inc. is a biopharmaceutical company developing small-molecule therapies that modulate genetically determined chromatin regulatory dependencies, including inhibitors and protein degraders targeting BRG1/BRM, BRD9, and other chromatin regulators such as BRM and ARID1B. Its programs are aimed at treating metastatic uveal melanoma, relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome, and certain cancers including synovial sarcoma and ovarian, endometrial, colorectal, bladder, and gastric cancers.

Valuation — source: SEC EDGAR (first-party)
Price$4.17
Market Cap$251.30M
P/E Ratio-3.5
EV / EBITDA-1.9
Price / Book-3.19
Price / Sales8.63
DCF Value (model)$-23.55
DCF Upside vs Price-664.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$30.91M
Net Margin-240.3%
Return on Equity98.6%
Current Ratio2.92
Revenue Growth (YoY)36.8%
EPS Growth (YoY)-25.3%
FCF Growth (YoY)-15.0%
Financial Health — source: SEC EDGAR
Altman Z-Score-4.65 (distress)
Valuation vs Sector & Industry
Stock P/E-3.5
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-117.0%
vs Industry-120.8%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFlagship Pioneering, LLC ($60.58M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOAdrian H. Gottschalk
Employees112
CountryUS
IPO Date2020-10-23

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Allogene Therapeutics, Inc. (ALLO)
  • Neumora Therapeutics, Inc. Common Stock (NMRA)
  • Aldeyra Therapeutics, Inc. (ALDX)
  • Candel Therapeutics, Inc. (CADL)
  • Lifecore Biomedical, Inc. (LFCR)
  • Jyong Biotech Ltd. Ordinary Shares (MENS)
  • Benitec Biopharma Inc. (BNTC)
  • Puma Biotechnology, Inc. (PBYI)
FHTX earnings history · FHTX institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.